Cite
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.
MLA
Khanna, Sahil, et al. “A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium Difficile Infection.” Journal of Infectious Diseases, vol. 214, no. 2, July 2016, pp. 173–81. EBSCOhost, https://doi.org/10.1093/infdis/jiv766.
APA
Khanna, S., Pardi, D. S., Kelly, C. R., Kraft, C. S., Dhere, T., Henn, M. R., Lombardo, M.-J., Vulic, M., Ohsumi, T., Winkler, J., Pindar, C., McGovern, B. H., Pomerantz, R. J., Aunins, J. G., Cook, D. N., & Hohmann, E. L. (2016). A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection. Journal of Infectious Diseases, 214(2), 173–181. https://doi.org/10.1093/infdis/jiv766
Chicago
Khanna, Sahil, Darrell S. Pardi, Colleen R. Kelly, Colleen S. Kraft, Tanvi Dhere, Matthew R. Henn, Mary-Jane Lombardo, et al. 2016. “A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium Difficile Infection.” Journal of Infectious Diseases 214 (2): 173–81. doi:10.1093/infdis/jiv766.